ClariTrial | Search Clinical Trials

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

588 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial

Phase 1Phase 2Critical IllnessPost Operative ComplicationThoracic Surgery

Self-balancing robotic exoskeleton (Atalante X)

Wandercraft5 participants1 site · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Phase 2Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)

Dapagliflozin 10 mgPlacebo

University Medical Centre Ljubljana100 participants1 site · SloveniaCompletes Nov 2028

Compare CT.gov Full analysis →

Recruiting

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Phase 2Chronic Kidney Disease Requiring Hemodialysis

iSGLT2

Maximo Agustin Schiavone80 participants1 site · ArgentinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

Phase 3Nitric OxideCardiac SurgeryCardiopulmonary Bypass

Nitric Oxide GasStandard Care Arm

Xijing Hospital3,650 participants3 sites · United States, China, RussiaCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

Phase 1Phase 2Prostate CancerSupportive Care

Exercise Training InterventionHealthy Living Education

Virginia Commonwealth University60 participants2 sites · United StatesCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Phase 1Phase 2Pulmonary Arterial Hypertension PAH

IMC-003 and PAH background therapyIMC-003 placebo and PAH background therapy

ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.120 participants29 sites · ChinaCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Phase 2Erectile Dysfunction Due to Arterial DiseaseAtherosclerosesErectile Disfunction

Pitavastatin 1-4 mg dailyRosuvastatin 20-40 mg daily

Lomonosov Moscow State University Medical Research and Educational Center150 participants1 site · RussiaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Venous Ethanol for Ventricular Tachycardia

Phase 2Ventricular TachycardiaIschemic Cardiomyopathy

Venous ethanolCatheter ablation

The Methodist Hospital Research Institute156 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Phase 1Phase 2TumorCardiovascular DiseasesPulmonary Fibrosis

Injection of 68Ga-NI-FAPI

Peking Union Medical College Hospital30 participants1 site · ChinaCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Phase 3Symptomatic Genetic Dilated Cardiomyopathy (DCM)

Danicamtiv

Kardigan, Inc.332 participants78 sites · United States, Belgium, DenmarkCompletes Nov 2032

Compare CT.gov Full analysis →

Recruiting

A Trial of CRD-4730 in HFrEF

Phase 2Heart Failure With Reduced Ejection Fraction (HFrEF)

CRD-4730Placebo

Cardurion Pharmaceuticals, Inc.525 participants2 sites · United StatesCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Phase 2Urothelial Carcinoma

disitamab vedotinpembrolizumab

Seagen, a wholly owned subsidiary of Pfizer372 participants221 sites · United States, Argentina, AustraliaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Phase 3Coronary Artery DiseaseSubclinical Atherosclerotic Cardiovascular Disease

Prescription of AspirinNo prescription

Montreal Heart Institute48 participants1 site · CanadaCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Phase 2Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis

HBI0101 CART

Polina Stepensky180 participants1 site · IsraelCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

Phase 1Phase 2Heart FailureIschemic Heart FailureIschemic Heart Disease

HS-005

Heartseed Inc.14 participants5 sites · JapanCompletes Jan 2028

Compare CT.gov Full analysis →

1–15 of 588

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

588 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial

Phase 1Phase 2Critical IllnessPost Operative ComplicationThoracic Surgery

Self-balancing robotic exoskeleton (Atalante X)

Wandercraft5 participants1 site · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Phase 2Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)

Dapagliflozin 10 mgPlacebo

University Medical Centre Ljubljana100 participants1 site · SloveniaCompletes Nov 2028

Compare CT.gov Full analysis →

Recruiting

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Phase 2Chronic Kidney Disease Requiring Hemodialysis

iSGLT2

Maximo Agustin Schiavone80 participants1 site · ArgentinaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

Phase 3Nitric OxideCardiac SurgeryCardiopulmonary Bypass

Nitric Oxide GasStandard Care Arm

Xijing Hospital3,650 participants3 sites · United States, China, RussiaCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

Phase 1Phase 2Prostate CancerSupportive Care

Exercise Training InterventionHealthy Living Education

Virginia Commonwealth University60 participants2 sites · United StatesCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Phase 1Phase 2Pulmonary Arterial Hypertension PAH

IMC-003 and PAH background therapyIMC-003 placebo and PAH background therapy

ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.120 participants29 sites · ChinaCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Phase 2Erectile Dysfunction Due to Arterial DiseaseAtherosclerosesErectile Disfunction

Pitavastatin 1-4 mg dailyRosuvastatin 20-40 mg daily

Lomonosov Moscow State University Medical Research and Educational Center150 participants1 site · RussiaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Venous Ethanol for Ventricular Tachycardia

Phase 2Ventricular TachycardiaIschemic Cardiomyopathy

Venous ethanolCatheter ablation

The Methodist Hospital Research Institute156 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Phase 1Phase 2TumorCardiovascular DiseasesPulmonary Fibrosis

Injection of 68Ga-NI-FAPI

Peking Union Medical College Hospital30 participants1 site · ChinaCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Phase 3Symptomatic Genetic Dilated Cardiomyopathy (DCM)

Danicamtiv

Kardigan, Inc.332 participants78 sites · United States, Belgium, DenmarkCompletes Nov 2032

Compare CT.gov Full analysis →

Recruiting

A Trial of CRD-4730 in HFrEF

Phase 2Heart Failure With Reduced Ejection Fraction (HFrEF)

CRD-4730Placebo

Cardurion Pharmaceuticals, Inc.525 participants2 sites · United StatesCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Phase 2Urothelial Carcinoma

disitamab vedotinpembrolizumab

Seagen, a wholly owned subsidiary of Pfizer372 participants221 sites · United States, Argentina, AustraliaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Phase 3Coronary Artery DiseaseSubclinical Atherosclerotic Cardiovascular Disease

Prescription of AspirinNo prescription

Montreal Heart Institute48 participants1 site · CanadaCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Phase 2Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis

HBI0101 CART

Polina Stepensky180 participants1 site · IsraelCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

Phase 1Phase 2Heart FailureIschemic Heart FailureIschemic Heart Disease

HS-005

Heartseed Inc.14 participants5 sites · JapanCompletes Jan 2028

Compare CT.gov Full analysis →

1–15 of 588